Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H21F3N2O4S |
Molecular Weight | 478.484 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(SC(=N1)C2=CC=C(C=C2)C(F)(F)F)C(=O)NCC3=CC=C(OC(C)(C)C(O)=O)C=C3
InChI
InChIKey=ILUPZUOBHCUBKB-UHFFFAOYSA-N
InChI=1S/C23H21F3N2O4S/c1-13-18(33-20(28-13)15-6-8-16(9-7-15)23(24,25)26)19(29)27-12-14-4-10-17(11-5-14)32-22(2,3)21(30)31/h4-11H,12H2,1-3H3,(H,27,29)(H,30,31)
Molecular Formula | C23H21F3N2O4S |
Molecular Weight | 478.484 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
GW 590735 is a selective and potent agonist of peroxisome proliferator-activated receptor alpha (PPARα), a ligand-activated transcription factor that plays a key role in lipid homeostasis. Activation of PPARα results in increased clearance of triglyceride (TG) rich very low-density lipoprotein. GW 590735 was in phase II clinical trial for the treatment of dyslipidemia, but that study was discontinued.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL239 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17243659 |
4.0 nM [EC50] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
Cmax
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
1461 ng/mL EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17243659 |
3 mg/kg single, oral dose: 3 mg/kg route of administration: Oral experiment type: SINGLE co-administered: |
GW-590735 plasma | Rattus norvegicus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
T1/2
Value | Dose | Co-administered | Analyte | Population |
---|---|---|---|---|
2.4 h EXPERIMENT https://pubmed.ncbi.nlm.nih.gov/17243659 |
2.7 mg/kg single, intravenous dose: 2.7 mg/kg route of administration: Intravenous experiment type: SINGLE co-administered: |
GW-590735 plasma | Rattus norvegicus population: UNKNOWN age: ADULT sex: UNKNOWN food status: UNKNOWN |
PubMed
Title | Date | PubMed |
---|---|---|
PPAR-beta/delta agonists for Type 2 diabetes and dyslipidemia: an adopted orphan still looking for a home. | 2008 Oct |
|
Ligand-enhanced expression and in-cell assay of human peroxisome proliferator-activated receptor alpha ligand binding domain. | 2010 Apr |
|
Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice. | 2010 Jun |
Patents
Sample Use Guides
eight weeks treatment with 1µg to 20µg daily doses of GW590735 in otherwise healthy subjects with low HDLc, mildly to moderately elevated TG, and normal LDLc
Route of Administration:
Unknown
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17243659
Curator's Comment: GW590735 shows EC50 = 4 nM on PPARalpha and at least 500-fold selectivity versus PPARdelta and PPARgamma.
Unknown
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:43:17 GMT 2023
by
admin
on
Fri Dec 15 15:43:17 GMT 2023
|
Record UNII |
QKY617BBX5
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
9956726
Created by
admin on Fri Dec 15 15:43:17 GMT 2023 , Edited by admin on Fri Dec 15 15:43:17 GMT 2023
|
PRIMARY | |||
|
QKY617BBX5
Created by
admin on Fri Dec 15 15:43:17 GMT 2023 , Edited by admin on Fri Dec 15 15:43:17 GMT 2023
|
PRIMARY | |||
|
343321-96-0
Created by
admin on Fri Dec 15 15:43:17 GMT 2023 , Edited by admin on Fri Dec 15 15:43:17 GMT 2023
|
PRIMARY | |||
|
DB07215
Created by
admin on Fri Dec 15 15:43:17 GMT 2023 , Edited by admin on Fri Dec 15 15:43:17 GMT 2023
|
PRIMARY | |||
|
DTXSID90977813
Created by
admin on Fri Dec 15 15:43:17 GMT 2023 , Edited by admin on Fri Dec 15 15:43:17 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET -> ACTIVATOR |
EC50
|
||
|
TARGET -> ACTIVATOR |
EC50
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |